Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepaguard in NASH
NCT01210989Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phyllanthus urinaria in Nonalcoholic steatohepatitis (NASH), sponsored by The Chinese University of Hong Kong. Started May 2010; status: completed.
02
Drugs
phyllanthus urinaria
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01210989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210989.